Sumitomo Chemical (SOMMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,384,931 | 1,500,398 | 2,263,246 | 2,985,775 | 3,260,031 |
| Marketable Securities | 297,099 | 216,232 | 231,154 | 196,021 | 115,744 |
| Receivables | 3,919,318 | 4,278,152 | 4,463,392 | 5,886,282 | 5,894,824 |
| Inventories | 4,126,604 | 4,896,495 | 5,509,107 | 5,321,987 | 4,620,441 |
| Other current assets | 720,728 | 672,313 | 578,441 | 420,315 | 420,870 |
| TOTAL | $10,448,680 | $11,563,590 | $13,045,340 | $14,810,380 | $14,311,910 |
| Non-Current Assets | |||||
| PPE Net | 5,011,156 | 5,496,029 | 6,137,227 | 6,724,585 | 7,167,374 |
| Investments And Advances | 3,071,521 | 5,055,872 | 5,299,103 | 6,249,424 | 6,978,855 |
| Intangibles | 3,281,058 | 3,703,078 | 4,964,393 | 5,847,095 | 6,056,065 |
| Other Non-Current Assets | 890,155 | 1,331,681 | 1,378,657 | 1,568,706 | 1,528,196 |
| TOTAL | $12,253,890 | $15,586,660 | $17,779,380 | $20,389,810 | $21,730,490 |
| Total Assets | $22,702,570 | $27,150,240 | $30,824,720 | $35,200,190 | $36,042,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,669,087 | 4,042,744 | 2,937,082 | 2,134,815 | 2,261,666 |
| Accounts payable and accrued liabilities | 3,221,671 | 3,749,350 | 3,817,401 | 4,506,765 | 4,723,033 |
| Other current liabilities | 1,850,871 | 2,053,550 | 2,456,955 | 2,746,246 | 2,520,152 |
| TOTAL | $6,855,730 | $9,960,061 | $9,459,916 | $9,588,128 | $9,851,793 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,819,357 | 6,745,309 | 7,877,026 | 8,899,338 | 9,941,984 |
| Other Non-Current Liabilities | 1,176,391 | 2,634,759 | 2,117,675 | 1,780,265 | 1,742,221 |
| TOTAL | $8,755,705 | $9,156,059 | $10,344,810 | $11,705,880 | $12,803,210 |
| Total Liabilities | $15,611,440 | $19,116,120 | $19,804,720 | $21,294,010 | $22,655,000 |
| Shareholders' Equity | |||||
| Common Shares | 594,389 | 620,572 | 664,594 | 732,895 | 810,216 |
| Retained earnings | 4,228,033 | 3,989,407 | 6,597,485 | 7,961,288 | 7,718,707 |
| Other shareholders' equity | 2,323,717 | 3,480,511 | 3,819,921 | 5,058,664 | 4,690,662 |
| TOTAL | $7,091,139 | $8,034,125 | $11,020,000 | $13,906,180 | $13,387,400 |
| Total Liabilities And Equity | $22,702,579 | $27,150,245 | $30,824,720 | $35,200,190 | $36,042,400 |